Lafutidine, a Protective H2 Receptor Antagonist, Enhances Mucosal Defense in Rat Esophagus by Akiba, Yasutada & Kaunitz, Jonathan D.
ORIGINAL ARTICLE
Lafutidine, a Protective H2 Receptor Antagonist, Enhances
Mucosal Defense in Rat Esophagus
Yasutada Akiba • Jonathan D. Kaunitz
Received: 21 April 2010/Accepted: 29 July 2010/Published online: 8 September 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Background Luminal acid or CO2 induces a hyperemic
response in the esophagus, via activation of acid sensors on
capsaicin-sensitive afferent nerves (CSAN). Since disrup-
tion of the hyperemic response to luminal CO2 acidiﬁes the
interstitium of the esophageal mucosa, the hyperemic
response may maintain interstitial pH (pHint). We hypoth-
esized that acid-related hyperemia maintains pHint, pre-
venting acid-induced injury in the esophageal mucosa.
Methods We examined the effects of capsaicin (Cap) or
lafutidine (Laf), a mucosal protective H2 antagonist, on the
regulation of pHint and blood ﬂow in rat esophagus using
ratiometric microimaging and laser-Doppler measurements
of the lower esophageal mucosa of living rats. The
esophagus was topically superfused with pH 7.0 buffer, or
a pH 1.0 or pH 1.0 ? pepsin (1 mg/ml) solution with or
without Laf.
Results Cap (30 or 100 lM) or Laf (0.1 or 1 mM) dose-
dependently increased blood ﬂow, accompanied by
increased pHint. The pH 1.0 solution increased blood ﬂow
without pHint change, whereas Laf (1 mM) increased blood
ﬂow and pHint during acid exposure. The effects of Laf
were abolished by ablation of CSAN. Perfusion of the
acidiﬁed pepsin solution gradually decreased pHint, inhib-
ited by Laf perfusion.
Conclusions Activation of CSAN by Laf with or without
acid, accompanied by hyperemia, increased pHint, pre-
venting acidiﬁed pepsin-induced interstitial acidiﬁcation.
Stimulation of the capsaicin pathway with compounds such
as Laf enhances mucosal protection from acid-related
injury in the upper gastrointestinal tract.
Keywords Esophageal blood ﬂow  Interstitial pH 
Capsaicin-sensitive afferent nerves  Pepsin 
Interstitial acidiﬁcation
Introduction
The upper gastrointestinal mucosa responds to luminal acid
by increasing HCO3
- and mucus secretion, increasing
mucosal blood ﬂow, and by increasing epithelial cellular
buffering in order to protect the mucosa from acid-induced
injury. These mucosal defense mechanisms appear to be
coordinated by the activation of submucosal acid sensors
[1, 2]. The duodenal mucosa is protected from injury due to
luminal acid by the ‘capsaicin pathway.’ In the duodenum,
the large luminal acid load originating from the stomach is
converted to the H
? equivalent CO2 at the cell surface prior
to absorption by the duodenal mucosa. CO2 at the entero-
cyte surface is absorbed into the enterocyte, facilitated by
ecto-carbonic anhydrases (CAs), followed by reconversion
to H
? by cellular CA and transport across the enterocyte
basolateral membrane into the subepithelial interstitium
[1, 3]. Subepithelial H
? interacts with submucosal acid
sensors such as transient receptor potential vanilloid 1
(TRPV1) expressed on submucosal capsaicin-sensitive
afferentnerves(CSAN),releasingthevasoactivecompounds
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DOI 10.1007/s10620-010-1379-ysuch as calcitonin gene-related peptide (CGRP) and nitric
oxide (NO), increasing mucosal blood ﬂow [3, 4]. In con-
trast to the ‘‘leaky’’ duodenal mucosa, the esophageal
mucosa, with tight intercellular junctions, responds to
luminal acid with hyperemia and increased pre-epithelial
layer gel thickness, but with no change of interstitial pH
(pHint)[ 5]. Nevertheless, CO2, rather than H
?, traverses the
epithelial layers, interacting with epithelial and neuronal
CAs and acid sensors, inducing the hyperemic response via
the activation of CSAN [6]. The esophageal mucosa thus
sharespartsofthecapsaicinpathwaywiththeduodenumasa
mucosal protective mechanism from injury due to reﬂuxed
gastric acid.
The hyperemic response to luminal acid is a well-stud-
ied defense mechanism in the esophagus [7–9]. Hyperemia
is believed to enhance the supply of HCO3
- to the mucosa
and the removal of H
? and CO2 from the mucosa during
acid exposure. HCO3
- delivery is an important esophageal
mucosal protective factor [10]. Luminal perfusion of a high
CO2 solution or of a pH 1.0 acid solution increases
esophageal blood ﬂow without affecting pHint [6]. Dis-
ruption of CO2-induced hyperemia by CA inhibition or
acid sensor inhibition irreversibly lowers pHint, implicated
in mucosal injury and the generation of noxious sensations
[6]. These results suggest that the hyperemic response to
luminal acid or high CO2 maintains pHint in the esophageal
mucosa during acid exposure. We thus hypothesized that
induction of hyperemia in the esophagus may increase
pHint, augmenting mucosal resistance to acid-induced
injury. Since the hyperemic response to luminal acid is
mediated via the capsaicin pathway, stimulation of acid
sensors expressed on CSAN and may also protect the
mucosa from injury.
Lafutidine (Laf), a histamine H2 receptor antagonist, has
a mucosal protective effect in addition to its antisecretory
properties via indirect stimulation or sensitization of CSAN
[11–15]. Laf is protective against experimental gastric
lesions even in the presence of supplementary potent anti-
secretory therapy, suggesting that it has a direct gastro-
protective effect in addition to its antisecretory properties
[15]. Laf reduces esophageal injury in the gastric acid reﬂux
model, apart from its antisecretory effect [13]. This pro-
tective effect is abolished by selectively ablating CSAN,
antagonism of CGRP and inhibition of NO synthase [16,
17], suggesting that the capsaicin pathway is integral to
Laf’s protective properties. We further hypothesized that
Laf enhances mucosal defenses by activating or sensitizing
mucosal acid-sensing mechanisms in rat esophagus.
We thus examined the effect of luminal superfusion of
capsaicin or Laf on pHint and blood ﬂow in rat esophagus.
Furthermore, we examined the effect of Laf on acidiﬁed
pepsin-induced changes in pHint and blood ﬂow, a surrogate
for esophageal injury. Our results showed that Laf-induced
hyperemia increased pHint and prevented interstitial acidi-
ﬁcation due to acidiﬁed pepsin via the activation of CSAN
in rat esophagus.
Methods
Chemicals and Animals
Laf was provided by Taiho Pharmaceutical Inc (Tokyo,
Japan). Laf, (±)-2(furfurylsulﬁnyl)-N-[4-[4-(piperidino-
methyl)-2-pyridyl]oxy-(Z)-2-butenyl]acetamide (431.54 g/
mol), is relatively lipophilic (log p = 0.39). 5’,6’-car-
boxyﬂuorescein (CF) was obtained from Molecular Probes
(Eugene, OR, USA). Capsaicin (Cap), porcine pepsin A,
HEPES, and other chemicals were obtained from Sigma
Chemical (St. Louis, MO, USA). Krebs solution contained
(in mM) 136 NaCl, 2.6 KCl, 1.8 CaCl2, and 10 HEPES at
pH 7.0. The pH 1.0 saline solution was made from 1 N HCl
with adding NaCl to adjust isotonicity. Each solution was
prewarmed to 37C using a water bath, and temperature was
maintained with a heating pad during the experiment.
For stock solutions, capsaicin was dissolved in 10%
Tween
-80, 10% EtOH, and 80% saline. The solution was
diluted with Krebs buffer in order to ensure that ﬁnal concen-
trations of Tween
-80, and EtOH were less than 0.1%. For
vehicleperfusion,Krebssolutionwith0.1%solventswasused.
Laf was initially dissolved in 1 N HCl and pH was adjusted to
pH 7 with the addition of 1 N NaOH. Stock solution of Laf
(50 mM) was diluted with pH 7.0 Krebs buffer before use.
All studies were performed with approval of the Vet-
erans Affairs Institutional Animal Care and Use Committee
(VA IACUC). Male Sprague–Dawley rats weighing
200–250 g (Harlan, San Diego, CA, USA) were fasted
overnight, but had free access to water.
Measurement of Blood Flow and Interstitial pH (pHint)
Esophageal blood ﬂow and pHint were simultaneously
measured in the lower esophagus as previously described
[5, 6]. In brief, under isoﬂurane anesthesia (1.5–2.0%) using
a rodent anesthesia inhalation system (Summit Medical
Systems, Bend, OR, USA), rats were placed supine on a
heating block system warmed with recirculating water
(SummitMedical)tomaintainbodytemperatureat36–37C,
as monitored by a rectal thermistor. Prewarmed saline was
infused via the right femoral vein at 1.08 ml/h using a
Harvard infusion pump (Harvard Apparatus, Holliston MA,
USA);bloodpressurewasmonitoredviaacatheterplacedin
the left femoral artery using a pressure transducer (Kent
Scientiﬁc, Torrington, CT, USA). The lower esophageal
mucosa was exposed and a concave stainless-steel disk
(16 mm in diameter and 1–2 mm deep) with a 3-mm central
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123aperture was ﬁxed watertight on the mucosal surface with a
silicone plastic adherent (Silly Putty, Binney & Smith,
Easton,PA,USA).Theserosalsurface ofthe esophagus was
supported with a right-angle laser-Doppler ﬂow probe
(R-type, Transonic, Ithaca, NY, USA) just below the cham-
beredmucosa.Athinplasticcoverslipwasﬁxedtothediskwith
the silicone adherent to permit closed superfusion with solu-
tions at a rate of 0.25 ml/min by means of a Harvard infusion
pump. Two PE-50 polyethylene perfusion lines were inserted
into the chamber to enable rapid changes of the perfusate.
Esophageal blood ﬂow was measured as the voltage
output of the laser-Doppler instrument (model BLF21,
Transonic) and expressed relative to the stable level (the
basal level) *30 min after the perfusion was started.
Blood ﬂow was continuously recorded with a strip chart
recorder and read every 5 min.
To measure pHint, the pH-sensitive, ﬂuorescent indicator
CF (5 mg/kg) in saline was intravenously injected 5 min
before the start of the experiment. Fluorescence of the
microscopically observed chambered area of esophageal
mucosa at 515-nm emission was recorded. Readings were
taken approximately 10 s before and after each measured
time point. The paired readings at 495- and 450-nm exci-
tation needed to calculate a ﬂuorescence ratio were thus
taken at a maximum of 20 s apart. The paired images were
captured every 5 min and analyzed by selecting three areas
of esophageal submucosa between microvessels, which
were followed throughout the experiment. In vitro cali-
bration was accomplished using an aqueous solution con-
taining 0.2 lM CF. In vitro calibration in solution and in
excised esophageal tissue revealed that the measurable pH
range using CF is between pH 6.0 and 7.5, as previously
reported [5]. We have conﬁrmed that despite a gradual
decrease in the ﬂuorescent intensity over time, the ﬂuo-
rescence ratio was stable during the 60-min experimental
period [5, 6]. We have also shown that there is a good
correlation between the measured pHint and arterial blood
pH [6], since in vivo calibration is technically difﬁcult.
Experimental Protocol
The exposed esophageal mucosa was superfused with
solutions via a mucosally placed perfusion chamber. Blood
ﬂow was stabilized during continuous perfusion of pH 7.0
Krebs buffer, after which the time was set as t = 0 min. At
t =- 5 min, CF was injected IV. The esophageal mucosa
was then superfused with pH 7.0 Krebs buffer from t = 0
until t = 10 min (basal period); the perfusate was then
changed to pH 7.0 Krebs containing vehicle, Cap (30 or
100 lM), or Laf (0.1 or 1 mM) from t = 10 until
t = 20 min (challenge period). The perfusate was changed
to the pH 7.0 solution from t = 20 until t = 35 min
(recovery period). For acid-perfusion experiments, the
mucosa was superfused with a pH 1.0 acid solution with or
without pepsin (1 mg/ml) or Laf (1 mM) from t = 10 until
t = 45 min (challenge period).
Ablation of CSAN was accomplished with high-dose
capsaicin pre-treatment (125 mg/kg sc) as described
previously [18]. Capsaicin-treated or vehicle (10%
Tween
-80, 10% EtOH, and 80% saline)-treated rats were
studied 10–14 days after the injections. Completeness of
de-afferentation was assessed by the 0.1% NH4OH eye
drop test. The esophageal mucosa of capsaicin-treated or
vehicle-treated rat was superfused with an acid solution
and Laf (1 mM) as described above.
Statistics
All data from six rats in each group were expressed as
means ± SEM. Comparisons between groups were made by
one-way ANOVA followed by Fisher’s least signiﬁcant dif-
ference test. p value less than 0.05 were taken as signiﬁcant.
Results
Effect of Luminal Perfusion of Cap or Laf
on Esophageal pHint and Blood Flow
We ﬁrst examined the effects of the TRPV1 agonist Cap
on pHint and mucosal blood ﬂow. Cap (30 or 100 lM)
increased esophageal blood ﬂow (Fig. 1b), consistent with
prior studies [7], accompanied by the interstitial alkalin-
ization (Fig. 1a). This result correlates the induction of
hyperemia with increased pHint. Similarly, Laf (0.1 or
1 mM) increased blood ﬂow, accompanied by a pHint
increase (Fig. 2a, b). The effects of Laf were abolished by
prior de-afferentation as a result of high-dose capsaicin
pretreatment (Cap-t) (Fig. 3a, b), suggesting that Laf-
induced hyperemia is mediated by the activation of
CSAN.
Effect of Laf on Acid-Induced Changes in Esophageal
pHint and Blood Flow
Since Laf increased pHint and blood ﬂow via the activation
of CSAN, we hypothesized that Laf enhances mucosal
protection during acid exposure in the esophagus. We per-
fused Laf during the basal and also during the challenge
periods in order to maximize its effects on mucosal defen-
ses. A pH 1.0 solution had no effect on pHint, but increased
blood ﬂow as previously reported [5, 6] (Fig. 4a, b). Laf
(1 mM) pretreatment increased pHint during coperfusion
with a neutral solution. Subsequent coperfusion of Laf with
a pH 1.0 solution increased pHint more than the pHint in the
pH 1.0 group during the acid challenge period (Fig. 4a). In
Dig Dis Sci (2010) 55:3063–3069 3065
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increased blood ﬂow during the basal period, followed by
an enhanced hyperemic response to acid perfusion com-
pared to the pH 1.0 group (Fig. 4b). Cap-t abolished the
Laf-induced pHint increase during the basal and acid chal-
lenge periods, and further acidiﬁed pHint during the acid
challenge period (Fig. 4a). This result is consistent with a
previous report showing that Cap-t irreversibly lowers pHint
during luminal perfusion of a high CO2 solution, consistent
with mucosal injury [6]. Furthermore, Cap-t abolished the
hyperemic response to acid ? Laf (Fig. 4b). Cap-t also
abolished the acid-induced hyperemia associated with
interstitial acidiﬁcation (data not shown). These results
suggest that luminal acid stimulates CSAN, and that Laf
enhances the hyperemic response to acid via CSAN acti-
vation or modulation, with a resultant increase of pHint.
Effect of Laf on Acidiﬁed Pepsin-Induced Changes
in Esophageal pHint and Blood Flow
We further hypothesized that Laf protects the mucosa from
the interstitial acidiﬁcation accompanying epithelial injury
or increased permeation of acid into the mucosa. We thus
examined the effect of acidiﬁed pepsin on pHint and blood
ﬂow, since acidiﬁed pepsin reduces electrical resistance of
rabbit esophagus in vitro and may thus also injure the rat
esophagus in vivo [19]. Pepsin (1 mg/ml) was added to the
pH 1.0 perfusate in order to compromise the mucosal bar-
rier. Acidiﬁed pepsin gradually, but markedly, decreased
pHint (Fig. 5a), consistent with increased H
? diffusion into
the mucosa. This pHint change was reversed by Laf (1 mM)
pre- and co-perfusion, consistent with mucosal protection
(Fig. 5a). Perfusion of the acidiﬁed pepsin solution tran-
siently increased blood ﬂow as did the acid alone, followed
by a second hyperemic response observed at t = 40–45 min
(Fig. 5b), associated with a markedly decreased pHint
(Fig. 5a). Laf increased blood ﬂow before and after acidi-
ﬁed pepsin superfusion, but prevented the secondary
hyperemia observed in acid ? pepsin group. These results
suggest that Laf treatment prevents the acidiﬁed pepsin-
induced mucosal injury in the esophagus by protective
hyperemia and pHint increase.
Discussion
We demonstrated that the induction of hyperemia with
luminal Cap or Laf increased esophageal blood ﬂow,
Fig. 1 Effect of luminal capsaicin (Cap) on interstitial pH (pHint) and
blood ﬂow in rat esophagus. pHint (a) and blood ﬂow (b) were
monitored during the luminal perfusion of Cap (30 and 100 lM) in rat
esophagus under in vivo microscopy. Cap increased the blood ﬂow,
accompanied by pHint increase. Data are expressed as mean ± SEM
(n = 6). * p\0.05 versus pH 7.0 Krebs group,
 p\0.05 versus
Cap (30 lM) group
Fig. 2 Effect of luminal lafutidine (Laf) on pHint and blood ﬂow.
Perfusion of Laf increased esophageal blood ﬂow (b), accompanied
by pHint increase (a). Data are expressed as mean ± SEM (n = 6).
* p\0.05 versus pH 7.0 Krebs group,
 p\0.05 versus pH
7.0 ? Laf (0.1 mM) group
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Laf enhanced acid-induced hyperemia with increased pHint
via the activation of CSAN, and prevented acidiﬁed pepsin-
induced interstitial acidiﬁcation. This is the ﬁrst study
to demonstrate that hyperemia protects the esophageal
mucosa due to increased pHint and that Laf locally
enhances esophageal mucosal defense mechanisms, apart
from its acid antisecretory effect as an H2 receptor
antagonist.
The esophageal mucosa responds to luminal acid by
augmenting its intrinsic defense mechanisms such as by
increasing mucosal blood ﬂow [5, 7]. Inhibition of the
hyperemic response during exposure to high luminal pCO2
lowers pHint [6], suggesting that reﬂex hyperemia main-
tains pHint homeostasis. Impairment of reﬂex hyperemia
lowers pHint, presumably by impairing the ability of the
enhanced mucosal blood ﬂow to remove acid and CO2, and
to deliver HCO3
-. In multiple tissues, interstitial acidiﬁ-
cation is sensed by neuronal chemosensors, producing
noxious sensations [20–22]. Thus, a clinical equivalent to
the tissue acidiﬁcation observed in the acid ? pepsin group
would likely be perceived as heartburn or a similar painful
sensation. Furthermore, prolonged or marked acidiﬁcation
may eventually injure the affected tissue. Induction of
hyperemia via the activation of CSAN increased pHint,
preventing acidiﬁed pepsin-induced interstitial acidiﬁcat-
ion, supporting our hypothesis that the hyperemic response
maintains pHint, presumably preventing acid-related injury
of the esophageal mucosa.
Activation of the capsaicin pathway can be accom-
plished by luminal acid perfusion or by TRPV1 agonists
such as capsaicin. Capsaicin, which is the pungent com-
ponent of hot peppers, is perceived as a burning or hot
sensation, which limits its use as a therapeutic agent. The
precise mechanism by which Laf exerts its effects is
unknown; nevertheless, denervation of CSAN abrogates
the protective effects of Laf, suggesting involvement of the
capsaicin pathway. In vitro studies have failed to document
a direct interaction between Laf and TRPV1 [12, 14],
whereas Laf potentiates Cap-induced CGRP release from
the gastric mucosa [14], suggesting that Laf sensitizes
TRPV1 or interacts at alternate components of the capsa-
icin pathway. Our results demonstrated that luminal Laf
perfusion increased blood ﬂow in the absence of perfused
luminal acid and that Laf enhanced acid-induced
Fig. 3 Effect of capsaicin pretreatment (Cap-t) on Laf-induced
changes in pHint and blood ﬂow in rat esophagus. Animals were
pretreated with vehicle (veh-t) or high-dose capsaicin 10–14 days
before the experiments. Cap-t abolished the Laf-induced pHint
increase (a) and hyperemia (b). Data are expressed as mean ± SEM
(n = 6). * p\0.05 versus pH 7.0 Krebs group,
 p\0.05 versus
veh-t ? Laf group
Fig. 4 Effect of Laf with acid on pHint and blood ﬂow in rat
esophagus. A pH 1.0 solution was perfused with or without Laf
(1 mM). Laf was perfused during the basal and challenge periods
(0–20 min) in the pH 1.0 ? Laf and in the Cap-t (capsaicin
pretreated) ? pH 1.0 ? Laf groups. The boxes above the graphs
represent the perfusate combination for the corresponding groups.
Pretreatment with Laf increased pHint (a) and blood ﬂow (b), and
enhanced acid-induced hyperemia. Cap-t abolished the effects of Laf
perfusion and further decreased pHint. Data are expressed as
mean ± SEM (n = 6). * p\0.05 versus pH 7.0 Krebs group,
 p\0.05versuspH1.0group,
 p\0.05versus pH1.0 ? Lafgroup
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hypothesis that Laf sensitizes TRPV1 or submucosal
afferent nerves. Since Laf ingestion, perhaps due to its
indirect interaction with TRPV1, does not provoke a
burning sensation, it might prove useful in the therapy of
heartburn, acid-induced esophageal injury, and related
disorders.
Another ﬁnding is that the acute, local application of Laf
enhanced mucosal defenses in the esophagus, regardless of
its anti-acid secretory effect, since the perfused segment
was isolated from gastric acid. Luminal Laf increases
mucosal blood ﬂow, mediated by CSAN, in rat stomach
[11], similar to our results. Intragastric application of Laf
prevents acid reﬂux-induced esophageal injury via CSAN
in pylorus/forestomach-ligated rats [13], also consistent
with our results.
We observed a biphasic hyperemic response during
acidiﬁed pepsin superfusion. The initial hyperemia is
consistent with a direct acid effect, whereas the secondary
hyperemia might be due to mucosal injury resulting from
the profound interstitial acidiﬁcation resulting from the
increased acid permeability induced by acidiﬁed pepsin.
Sustained or repeated superfusion of the rabbit esophageal
mucosa over a period of days was necessary to injure the
esophagus in one study [23]. In another study, a 90-min
esophageal perfusion with a pH 1.4 solution ? 0.5% pep-
sin produced only edema or hyperemia in 8/9 rats [24].
Thus, macroscopic or measurable histologic injury in our
acute topical superfusion model may be difﬁcult to pro-
duce. Nevertheless, in the rat duodenum and many other
organs, irreversible cellular acidiﬁcation or tissue acidosis
usually precedes or is the cause of tissue injury [25].
Laf was topically perfused over the esophageal mucosa
in all of the experiments in which it was used, consistent
with a direct effect on the mucosa, in contradistinction to
the pharmacology of clinically used oral H2 receptor
antagonists, which must be absorbed from the intestine and
transported by the circulation to the gastric mucosa. Since
Laf is soluble at strongly acidic pH, Laf in gastric juice
may reﬂux into the esophagus and then protect the
esophageal mucosa in humans with acid reﬂux. Since Laf is
not absorbed from the stomach, the gastric juice concen-
tration resulting from an orally administered clinical dose
of Laf (10 mg) may reach *2 mM when gastric juice
volume is 10 ml, above the 0.1–1.0 mM we used in rats.
In conclusion, the induction of hyperemia via CSAN
increased pHint, preventing acid-induced interstitial acidi-
ﬁcation in rat esophagus. Laf activated CSAN and
enhanced mucosal defense mechanisms, protecting mucosa
from acid-pepsin injury. Our results support the therapeutic
strategy in which compounds stimulating the capsaicin
pathway such as Laf enhances mucosal protection from
acid-related injury in the upper gastrointestinal tract and
thus may uniquely protect from esophageal injury.
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